Sabarubicin is a disaccharide analog of doxorubicin studied as an active pharmaceutical ingredient for small cell lung cancer research. It has shown superior antitumor efficacy in preclinical studies, associated with activation of p53-independent apoptosis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sabarubicin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Idarubicin hydrochloride
pharmaceutical raw material
Idarubicin
pharmaceutical raw material
Diquafosol tetrasodium
pharmaceutical raw material
Gliclazide
pharmaceutical raw material
N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-(2-pyridinyl)-beta-alanine ethyl ester hydrochloride
pharmaceutical raw material
Dabigatran
pharmaceutical raw material
The international HS code for Sabarubicin (CAS 211100-13-9) is 2941.90.
2941.90
2941 90 00
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
(7S,9S)-7-[(2R,4S,5S,6S)-5-[(2S,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-8,10-dihydro-7H-tetracene-5,12-dione
VQHRZZISQVWPLK-UIRGBLDSSA-N
C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@@H]2[C@@H](O[C@H](C[C@@H]2O)O[C@H]3C[C@@](CC4=C3C(=C5C(=C4O)C(=O)C6=CC=CC=C6C5=O)O)(C(=O)CO)O)C)N)O
Sourcing Sabarubicin?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.